SCHEMBL362237

SCHEMBL362237

CON(C)C(=O)CC(c1ccc(Br)cc1)c1ccc(F)cc1F

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.41
NPSR1 Q6W5P4 2/20 0.38
TDP1 Q9NUW8 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
MAPT P10636 2/20 0.38
LMNA P02545 2/20 0.38
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CES2 O00748 1/20 0.36
CES1 P23141 1/20 0.36
ALDH1A1 P00352 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
GPBAR1 Q8TDU6 1/20 0.35
PKM P14618 1/20 0.35
TSHR P16473 1/20 0.35
DPP4 P27487 1/20 0.34
POLB P06746 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL363622 0.90 HPGD (0.40) HPGDNPSR1TDP1SMN1; SMN2MAPT
SCHEMBL362997 0.81 DPP4 (0.41) KMT2ACES2CES1GPBAR1PKM
SCHEMBL366084 0.78 LMNA (0.41) NPSR1TDP1SMN1; SMN2MAPTLMNA
SCHEMBL363757 0.78 LMNA (0.41) NPSR1TDP1SMN1; SMN2MAPTLMNA
SCHEMBL1395398 0.77 TDP1 (0.43) HPGDNPSR1TDP1SMN1; SMN2MAPT
SCHEMBL362062 0.77 GPBAR1 (0.46) HPGDNPSR1TDP1SMN1; SMN2MAPT
SCHEMBL362134 0.77 GPBAR1 (0.46) HPGDNPSR1TDP1SMN1; SMN2MAPT
SCHEMBL362061 0.77 GPBAR1 (0.46) HPGDNPSR1TDP1SMN1; SMN2MAPT
SCHEMBL363625 0.76 TACR1 (0.40) HPGDNPSR1TDP1SMN1; SMN2MAPT
SCHEMBL1390583 0.73 GPR183 (0.39) SMN1; SMN2MAPTLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
EP-2593426-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F.HOFFMANN-LA ROCHE AG (CH) 2013-05-22 EP disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 HPGD 602/4885NPSR1 319/4885TDP1 2650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.